Make sure you know how the deed to your marital home lists the title
By Lisa Spiwak When a married couple goes to the escrow office to sign the documents to their new home, they are thinking about many things. Their minds are swirling with thoughts of the mortgage payment, furniture placement, the moving company, landscaping, area schools, etc. The last thing they are thinking about is how the Read More →
Read More →
SOAR creates disparity in land values
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Rams spark home price surge in Ventura County
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Radius acquires Hagelis to broaden groups’ commercial real estate reach
Radius Group Commercial Real Estate has acquired the Hagelis Group. Santa Barbara-based Radius recently completed a deal that will expand its footprint and grow its brand. Hagelis specializes in retail properties in Ventura County, which will broaden Radius’ reach and expertise, said Brian Johnson of Radius, which predominantly works in the South County multifamily, office Read More →
Read More →Rams executive says team on mission to help Conejo Valley
Los Angeles Rams Chief Operating Officer Kevin Demoff spoke about a mission to help the Conejo Valley community, area businesses and California Lutheran University on Sept. 16. Demoff talked about the vision the team has for expanding football in the region, Olympic and Super Bowl bids for the Rams’ new Inglewood Stadium and the challenges Read More →
Read More →FDA approves biosimilar of Amgen’s Enbrel
The U.S. Food and Drug Administration formally approved a competing biosimilar of Amgen’s top-selling drug Enbrel on Aug. 30. Made by Switzerland-based Novartis, Erelzi mimics the effects of Enbrel. Enbrel, which was first approved in 1998, is approved to treat rheumatoid arthritis and other conditions by decreasing the amount of a protein produced by the Read More →
Read More →Amgen reports positive results for Prolia
Thousand Oaks-based biotech giant Amgen announced positive results from patients receiving Prolia to treat inflammation Aug. 29. In the study, Prolia, normally used to treat osteoporosis, hypercalcemia and bone cancer, was used to treat inflammation. The two-year study enrolled 795 patients to evaluate the safety of two 60 milligram doses of Prolia given under the Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
